Prolyl 4-hydroxylase inhibitor (HOE 077) inhibits pig serum-induced rat liver fibrosis by preventing stellate cell activation
- 31 July 1997
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 27 (1), 185-192
- https://doi.org/10.1016/s0168-8278(97)80300-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Contribution of immune response to the hepatic fibrosis induced by porcine serumHepatology, 1996
- Hepatic stellate (ITO) cells: expanding roles for a liver-specific pericyteJournal of Hepatology, 1995
- The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment StrategiesNew England Journal of Medicine, 1993
- Role of mesenchymal cell populations in porcine serum-induced rat liver fibrosisHepatology, 1992
- Prolyl 4-hydroxylase, a target enzyme for drug development: Design of suppressive agents and the in vitro effects of inhibitors and proinhibitorsJournal of Hepatology, 1991
- Beneficial effects of inhibitors of prolyl 4-hydroxylase in CCl4-induced fibrosis of the liver in ratsJournal of Hepatology, 1991
- General pharmacology, toxicology and future clinical development of HOE 077Journal of Hepatology, 1991
- Effects of the prolyl 4-hydroxylase proinhibitor HOE 077 on human and rat hepatocytes in primary cultureJournal of Hepatology, 1991
- Prolyl 4-hydroxylase and its role in collagen synthesisJournal of Hepatology, 1991
- Synthesis in vitro of Keratin Polypeptides Directed by mRNA Isolated from Newborn and Adult Mouse EpidermisEuropean Journal of Biochemistry, 1980